kesimpta
novartis ireland ltd - ofatumumab - sclerosis multiplex, relapsing-remitting - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
chantico kõvakapsel
g.l. pharma gmbh - fingolimood - kõvakapsel - 0,5mg 10tk; 0,5mg 28tk; 0,5mg 60tk; 0,5mg 30tk; 0,5mg 98tk; 0,5mg 7tk
fingolimod teva kõvakapsel
teva gmbh - fingolimood - kõvakapsel - 0,5mg 10tk; 0,5mg 98tk; 0,5mg 28tk; 0,5mg 100tk; 0,5mg 30tk
fingolimod medochemie kõvakapsel
medochemie limited - fingolimood - kõvakapsel - 0,5mg 98tk; 0,5mg 28tk; 0,5mg 7tk; 0,5mg 10tk; 0,5mg 30tk
efigalo kõvakapsel
krka, d.d., novo mesto - fingolimood - kõvakapsel - 0,5mg 60tk; 0,5mg 30tk; 0,5mg 98tk; 0,5mg 28tk; 0,5mg 14tk; 0,5mg 90tk; 0,5mg 100tk
fingolimod richter kõvakapsel
gedeon richter plc. - fingolimood - kõvakapsel - 0,5mg 7tk; 0,5mg 98tk; 0,5mg 28tk
fingolimod stada kõvakapsel
stada arzneimittel ag - fingolimood - kõvakapsel - 0,5mg 7tk; 0,5mg 28tk; 0,5mg 30tk
fingolimod remedica kõvakapsel
remedica limited - fingolimood - kõvakapsel - 0,5mg 98tk; 0,5mg 28tk; 0,5mg 7tk
fingolimod norameda kõvakapsel
norameda uab - fingolimood - kõvakapsel - 0,5mg 28tk; 0,5mg 98tk; 0,5mg 100tk
fingolimod zentiva kõvakapsel
zentiva k.s. - fingolimood - kõvakapsel - 0,5mg 28tk; 0,5mg 30tk; 0,5mg 7tk; 0,5mg 56tk